Medarex's Offer to Repurchase its Convertible Senior Notes due May 15, 2011 Expires
Oct 29, 2009 (Close-Up Media via COMTEX) --
Companies: Bristol-Myers Squibb Co. (BMY), Medarex, Inc. (MEDX)
Medarex, Inc., a subsidiary of Bristol-Myers Squibb Company has announced that its offer to repurchase its 2.25 percent Convertible Senior Notes due May 15, 2011 expired on October 23, pursuant to terms of the notice of change in control to holders of the Convertible Notes dated September 23.
The trustee for the Convertible Notes has advised Medarex that no Convertible Notes were tendered in the offer to repurchase.
((Comments on this story may be sent to health@closeupmedia.com))
Copyright (C) 2009 Close-Up Media. All rights reserved
News Provided by COMTEX
Companies: Bristol-Myers Squibb Co. (BMY), Medarex, Inc. (MEDX)
Related terms: health
Zibb.com
Zibb.co.uk
Zibb.fr
Zibbsearch.nl